Age groups (years) | N | Mean age (years) | Anti-PfMSP1p19 levelsa | % Positive respondersb | % High respondersb | ADRBc |
---|---|---|---|---|---|---|
DIELMO | ||||||
 0–6 | 19 | 4.6 | 3.6 [1–9.1] | 68 | 16 | 154 [46–354] |
 7–14 | 31 | 10.9 | 3.5 [1–15] | 48 | 13 | 231 [40–958] |
 ≥15 | 69 | 37.4 | 9.2 [1–16.9] | 87 | 62 | 380 [106–575] |
 All | 119 | 25.3 | 6.8 [1–16.9] | 74 | 42 | 305 [40–958] |
NDIOP | ||||||
 0–14 | 49 | 8.8 | 6.4 [1–18.4] | 80 | 37 | 162 [51–545] |
 15–29 | 33 | 20.5 | 9.2 [1–19.7] | 88 | 55 | 307 [113–1721] |
 ≥30 | 32 | 43.9 | 11.9 [1–19.9] | 94 | 69 | 370 [56–1147] |
 All | 114 | 21.8 | 8.8 [1–19.9] | 86 | 51 | 262 [51–1721] |